Carine Bécamel

8PUBLICATIONS
26CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Molecular medicineCheminformatics and quantitative structure-activity relationshipsPersonality and individual differencesNeurology and neuromuscular diseases
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jul 23, 2025
Nanobody therapy rescues behavioural deficits of NMDA receptor hypofunction.

Mathieu Oosterlaken, Angelina Rogliardo, Tatiana Lipina

|Jan 11, 2024
Antidepressant-like effects of psychedelics in a chronic despair mouse model: is the 5-HT2A receptor the unique player?

Mehdi Sekssaoui, Joël Bockaert, Philippe Marin

|Oct 05, 2023
Superiority of the Triple-Acting 5-HT6R/5-HT3R Antagonist and MAO-B Reversible Inhibitor PZ-1922 over 5-HT6R Antagonist Intepirdine in Alleviation of Cognitive Deficits in Rats.

Katarzyna Grychowska, Uriel López-Sánchez, Mathieu Vitalis

|Apr 22, 2022
Effects of a psychedelic 5-HT2A receptor agonist on anxiety-related behavior and fear processing in mice.

Błażej D Pędzich, Sarah Rubens, Mehdi Sekssaoui

|Sep 28, 2021
Blockade of Serotonin 5-HT6 Receptor Constitutive Activity Alleviates Cognitive Deficits in a Preclinical Model of Neurofibromatosis Type 1.

Emilie Doucet, Katarzyna Grychowska, Pawel Zajdel

|Apr 25, 2020
Early 5-HT6 receptor blockade prevents symptom onset in a model of adolescent cannabis abuse.

Coralie Berthoux, Al Mahdy Hamieh, Angelina Rogliardo

Pageof 2

Frequent Collaborators

5 joint publications

Philippe Marin

2 joint publications

Pawel Zajdel

1 joint publications

Emmanuel Valjent

1 joint publications

Katarzyna Grychowska